CHARLES E. HOLMAN FOUNDATION

CHARLES E. HOLMAN FOUNDATION The Charles E. Holman Foundation is a 501 c 3 non-profit organization supporting research, education, diagnosis and treatment of Morgellons Disease.

We utilize creative confrontation to expose any person or group opposing or inhibiting education, awareness or recognition of Morgellons Disease. Holman Foundation exists to play an integral role in spreading the understanding of Morgellons Disease to others.

05/18/2026
Watch Dr. Horowitz’s webinar with n relationship between chronic Lyme and Alzheimer’s here
05/15/2026

Watch Dr. Horowitz’s webinar with n relationship between chronic Lyme and Alzheimer’s here

Experts estimate that 42% of people over age 55 will develop some form of dementia during their lifetime. Dr. Richard Horowitz has an important message

Many of the most commonly asked questions are discussed in this interview.  Questions like Why does the medical communit...
05/15/2026

Many of the most commonly asked questions are discussed in this interview. Questions like
Why does the medical community dismiss Lyme disease?
Why can’t I get proper testing for Lyme that’s covered by insurance?
Why can’t I get treatment for my tick borne illness that’s covered by insurance?
How can this medical dismissal be happening in the USA in 2026?
Is there any hope?

Britt Girvan with “What the Morg” podcast interviews Kris Newby, producer of Under Our Skin documentary and author of book “Bitten”.

Extremely interesting and informative interview. Check it out here:

In this episode of What The Morgs? Podcast, host and Lyme & Morgellons Awareness Advocate Britt Girvan sits down with award-winning science writer Kris Newby...

https://stopthethyroidmadness.com/lyme-disease/?fbclid=IwdGRleARwip9leHRuA2FlbQIxMQBzcnRjBmFwcF9pZA8xNzM4NDc2NDI2NzAzNzA...
05/12/2026

https://stopthethyroidmadness.com/lyme-disease/?fbclid=IwdGRleARwip9leHRuA2FlbQIxMQBzcnRjBmFwcF9pZA8xNzM4NDc2NDI2NzAzNzAAAR5iiiRU__AvTtN3_U25H6SDFmKBejcBkuJWf4cHVYTpsbJC2KPVHjLWteR87w_aem_zYt_eIgwQJNqYFX0ktxJeQ

This informative article below has been written by thyroid/adrenal patient Dana. Read it VERY carefully, as it may have answers for you! I, Dana, became interested in the link between Lyme Disease (LD) and Hypothyroidism after my own young son contracted Lyme Disease in the late summer of 2005. Belo...

05/12/2026

GInger Savely discusses Morgellons fibers on What the Morgs podcast.

Many of you may remember Samantha Rice from her presentations on Morgellons research at several of our conferences in Au...
05/10/2026

Many of you may remember Samantha Rice from her presentations on Morgellons research at several of our conferences in Austin, TX. Samantha has worked diligently and tirelessly on Morgellons for many years now as a grad student under direction of Dr. Randy Wymore. Today was 2026 commencement at OSU-CHS and Samantha was formally hooded by Dr. Wymore as a PhD Biomedical Scientist! We are thrilled and proud beyond words by Samantha’s academic achievements and especially her dedication to research on Morgellons. I got teary watching the commencement on You Tube as I know personally how long and hard Samantha has worked for this moment. Through several serious illnesses of her own and many life obstacles, she never wavered. Samantha always remained committed to establishing Morgellons as a real physiological disease and to discovering the fastidious pathogens involved in this unusual dermopathy.

And the best part of this story is that Samantha will stay at OSU-CHS and continue to work on Morgellons disease research! GO SAMANTHA! We are so proud of you and so grateful for all you do to improve the lives of Morgellons patients worldwide.

GO POKES! GO SAMANTHA! And GO MORGELLONS RESEARCH!

Address

P. O. Box 1109
Lone Star, TX
75668

Alerts

Be the first to know and let us send you an email when CHARLES E. HOLMAN FOUNDATION posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CHARLES E. HOLMAN FOUNDATION:

Featured

Share